Clinical trial
PERi-operative Selective Decontamination of the Digestive Tract to Prevent Severe Infectious Complications After Esophagectomy: a Randomized Multicenter Clinical Trial in Patients with Primary Resectable Esophageal Carcinoma (cT1-4, N0-3, M0)
NCT05865743 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PERi-operative Selective Decontamination of the Digestive Tract to Prevent Severe Infectious Complications After Esophagectomy: a Randomized Multicenter Clinical Trial in Patients with Primary Resectable Esophageal Carcinoma (cT1-4, N0-3, M0)
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 21, 2024
- Completion date
- June 30, 2028
- Enrollment
- 854 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer